Search results
Girl, 17, diagnosed with stage 4 cancer after doctors said her back pain was a pulled muscle
TODAY via Yahoo News· 5 months agoIn late 2022, Shimia Nord experienced such intense back pain that she failed her driver’s test....
New hope for kidney cancer treatment using existing drugs
Press Association News via AOL· 2 years agoResearchers say a new study of kidney cancer offers hope for treating the disease using existing...
Biotech Stock Roundup: EXEL Partners RCUS for Study, PHVS & EYPT Gain on Study Data
Zacks via Yahoo Finance· 7 months agoIt was a busy week for the biotech sector, with numerous study readouts and other updates. Quite a...
Will Keytruda & Gardasil Aid Merck (MRK) Sales in Q4 Earnings?
Zacks via Yahoo Finance· 1 year agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor, Keytruda,...
FDA Expands Merck's (MRK) Welireg Label in Renal Cell Carcinoma
Zacks via Yahoo Finance· 6 months agoPer Merck (MRK), the latest FDA approval to Welireg marks the first time a new treatment has been...
US FDA approves Merck's drug for kidney cancer
Reuters via Yahoo News· 6 months agoThe drug, branded as Welireg, is used to treat patients with renal cell carcinoma who have received prior treatment. Renal cell carcinoma is a disease in...
7 Myths About Kidney Cancer, Debunked
Time via Yahoo News· 1 year agodoctor holding orange ribbon. campaign to prevent skin cancer, melanoma, December orange Credit - Leonidas Santana—Getty Images Kidney cancer may well be...
Signs and Symptoms of Kidney Cancer
Health via Yahoo News· 2 months agourbazon / Getty Images Medically reviewed by Gagandeep Brar, MD Your kidneys remove waste products from your blood and flush out toxins from your body through your urine. These internal organs ...
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
Benzinga via Yahoo Finance· 1 year agoExelixis Inc (NASDAQ: EXEL) announced that the phase 3 CONTACT-03 study did not meet its primary...
BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial
Clinical Trials Arena via Yahoo Finance· 1 month agoBristol Myers Squibb’s (BMS) blockbuster cancer therapies Opdivo (nivolumab) and Yervoy (ipilimumab)...